Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | TRE-515 |
Synonyms | |
Therapy Description |
TRE-515 inhibits deoxycytidine kinase, potentially resulting in decreased tumor growth (PMID: 35986643, Cancer Res (2022) 82 (12_Supplement): 2635). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TRE-515 | TRE515|TRE 515|DI 87 | TRE-515 inhibits deoxycytidine kinase, potentially resulting in decreased tumor growth (PMID: 35986643, Cancer Res (2022) 82 (12_Supplement): 2635). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05055609 | Phase I | TRE-515 | Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors | Recruiting | USA | 0 |